Jarvis MF - Search Results

1

Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.

Illes P, Müller CE, Jacobson KA, Grutter T, Nicke A, Fountain SJ, Kennedy C, Schmalzing G, Jarvis MF, Stojilkovic SS, King BF, Di Virgilio F. Illes P, et al. Among authors: jarvis mf. Br J Pharmacol. 2021 Feb;178(3):489-514. doi: 10.1111/bph.15299. Epub 2020 Dec 21. Br J Pharmacol. 2021. PMID: 33125712 Free PMC article. Review.

2

Agonist derived molecular probes for A2 adenosine receptors.

Jacobson KA, Pannell LK, Ji XD, Jarvis MF, Williams M, Hutchison AJ, Barrington WW, Stiles GL. Jacobson KA, et al. Among authors: jarvis mf. J Mol Recognit. 1989 Dec;2(4):170-8. doi: 10.1002/jmr.300020406. J Mol Recognit. 1989. PMID: 2561548 Free PMC article.

3

Autoradiographic localization of adenosine A1 receptors in rat brain using [3H]XCC, a functionalized congener of 1,3-dipropylxanthine.

Jarvis MF, Jacobson KA, Williams M. Jarvis MF, et al. Neurosci Lett. 1987 Oct 16;81(1-2):69-74. doi: 10.1016/0304-3940(87)90342-9. Neurosci Lett. 1987. PMID: 3696476 Free PMC article.

4

Pharmacological characterization of recombinant human and rat P2X receptor subtypes.

Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM, Park HS, Yu H, Metzger R, Kowaluk E, Jarvis MF, van Biesen T. Bianchi BR, et al. Among authors: jarvis mf. Eur J Pharmacol. 1999 Jul 2;376(1-2):127-38. doi: 10.1016/s0014-2999(99)00350-7. Eur J Pharmacol. 1999. PMID: 10440098

5

Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X(3) allosteric modulator, cibacron blue.

Jarvis MF, Wismer CT, Schweitzer E, Yu H, van Biesen T, Lynch KJ, Burgard EC, Kowaluk EA. Jarvis MF, et al. Br J Pharmacol. 2001 Jan;132(1):259-69. doi: 10.1038/sj.bjp.0703793. Br J Pharmacol. 2001. PMID: 11156585 Free PMC article.

6

Antagonism of P2X3-containing channels: commentary on Spelta et al.

Jarvis MF, Burgard EC. Jarvis MF, et al. Br J Pharmacol. 2002 Mar;135(6):1343-4. doi: 10.1038/sj.bjp.0704590. Br J Pharmacol. 2002. PMID: 11906944 Free PMC article. No abstract available.

7

Purine and pyrimidine (P2) receptors as drug targets.

Jacobson KA, Jarvis MF, Williams M. Jacobson KA, et al. Among authors: jarvis mf. J Med Chem. 2002 Sep 12;45(19):4057-93. doi: 10.1021/jm020046y. J Med Chem. 2002. PMID: 12213051 Review. No abstract available.

8

2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.

Neelands TR, Burgard EC, Uchic ME, McDonald HA, Niforatos W, Faltynek CR, Lynch KJ, Jarvis MF. Neelands TR, et al. Among authors: jarvis mf. Br J Pharmacol. 2003 Sep;140(1):202-10. doi: 10.1038/sj.bjp.0705411. Epub 2003 Jul 29. Br J Pharmacol. 2003. PMID: 12967950 Free PMC article.

9

Effects of A-317491, a novel and selective P2X3/P2X2/3 receptor antagonist, on neuropathic, inflammatory and chemogenic nociception following intrathecal and intraplantar administration.

McGaraughty S, Wismer CT, Zhu CZ, Mikusa J, Honore P, Chu KL, Lee CH, Faltynek CR, Jarvis MF. McGaraughty S, et al. Among authors: jarvis mf. Br J Pharmacol. 2003 Dec;140(8):1381-8. doi: 10.1038/sj.bjp.0705574. Epub 2003 Nov 17. Br J Pharmacol. 2003. PMID: 14623769 Free PMC article.

10

Endogenous opioid mechanisms partially mediate P2X3/P2X2/3-related antinociception in rat models of inflammatory and chemogenic pain but not neuropathic pain.

McGaraughty S, Honore P, Wismer CT, Mikusa J, Zhu CZ, McDonald HA, Bianchi B, Faltynek CR, Jarvis MF. McGaraughty S, et al. Among authors: jarvis mf. Br J Pharmacol. 2005 Sep;146(2):180-8. doi: 10.1038/sj.bjp.0706346. Br J Pharmacol. 2005. PMID: 16041397 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page